EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models

Apeng Chen, Yapeng Chao, Han Zou, Lauren H McCarl, Gary Kohanbash, Baoli Hu

STAR Protocols · 2023

DOI: 10.1016/j.xpro.2023.102049 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift STAR Protocols, 2023. Verfasst von Apeng Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, 730…. Hauptthemen laut MEDLINE: Glioma, Glioblastoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the glioblastoma (GBM) immune microenvironment and development of clinical treatment drugs rely on suitable preclinical GBM models. Here, we present a protocol to establish syngeneic orthotopic glioma mouse models. We also describe the steps to intracranially deliver immunotherapeutic peptides and monitor the treatment response. Finally, we show how to assess the tumor immune microenvironment with treatment outcomes. For complete details on the use and execution of this protocol, please refer to Chen et al. (2021).1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaGlioblastomaAnimalsMiceCell Line, TumorDisease Models, AnimalImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

CancerHealth SciencesModel OrganismsNeuroscience

Autor:innen und Institutionen

  • State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, 730046, China. Electronic address: chenapeng@caas.cn.
  • Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; John G. Rangos Sr. Research Center, University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh,…

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • National Natural Science Foundation of China
  • Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences
  • National Institute of Neurological Disorders and Stroke
  • National Institutes of Health
  • Children's Hospital of Pittsburgh
  • Natural Science Foundation of Gansu Province

Zitieren

APA

Chen, A., Chao, Y., Zou, H., McCarl, L. H., Kohanbash, G., & Hu, B. (2023). Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models. STAR Protocols. https://doi.org/10.1016/j.xpro.2023.102049

Vancouver

Chen A, Chao Y, Zou H, McCarl LH, Kohanbash G, Hu B. Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models. STAR Protocols. 2023. doi:10.1016/j.xpro.2023.102049

BibTeX
@article{Chen2023,
  author = {Chen, Apeng and Chao, Yapeng and Zou, Han and McCarl, Lauren H and Kohanbash, Gary and Hu, Baoli},
  title = {Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models},
  journal = {STAR Protocols},
  year = {2023},
  doi = {10.1016/j.xpro.2023.102049}
}
Kostenlos starten →